Semma Therapeutics' Series B Round

Semma Therapeutics raised a round of funding on November 30, 2017.

Semma Therapeutics is a biopharmaceutical company developing Stem Cell-derived Islet therapy for type 1 diabetes.…

Articles about Semma Therapeutics' Series B Round: